pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,472 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT995Endpoints759BioPharma Dive291BioSpace196Fierce Biotech189onclive165globenewswire health73raps
therapy area
allOncology5813Rare Disease1332Cardiology1076Immunology976Hematology976Pulmonology880Vaccines
  • US faces critical shortage of forensic pathologists, delaying justice and public health
    The United States is experiencing a severe deficit of forensic pathologists, with roughly 850 currently practicing-about 400 fewer than experts say are needed to handle more than three million deat…
    STAT · 1mo agoNegative↗ source
  • Dementia prevention trial in Latin America replicates earlier promising results with culturally tailored risk-reduction program
    A new dementia prevention study presented at the Alzheimer’s Association International Conference showed results that mirror earlier findings, reinforcing the value of structured risk‑reduction pro…
    STAT · 1mo agoPositive readoutPositive↗ source
← prev
page 41 of 99
next →
70
fda recalls44
fda medwatch33
fda press26
834
Psychiatry & CNS701
Ophthalmology412
Pain359
Endocrinology & Metabolism358
Infectious Disease344
  • UnitedHealth touts home-care audit but its 97% justification claim faces scrutiny as insurers sue CMS over MA ratings
    UnitedHealth Group promoted a new audit that claims 97% of diagnoses recorded for its Medicare Advantage members during home visits are supported by medical records. The company presented the findi…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Biogen tau therapy data and FDA clears Sanofi wearable injector as biotech news heats up
    Researchers at a recent pancreatic cancer conference highlighted the potential of daraxonrasib, while an Alzheimer’s gathering placed tau‑targeting therapies at the forefront of discussion. In the…
    STAT · 1mo agoNeutral↗ source
  • Caregivers Face Pay Cuts and Housing Risks as States Trim Medicaid Funding
    States are beginning to slash budgets to comply with the Republican One Big Beautiful Bill Act, which aims to reduce Medicaid spending by roughly $1 trillion over the next decade. The reductions f…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Biotech venture funding hits $9.1 billion in H1 2026, but small startups lag behind
    Venture capital funding for biotech startups surged in the first half of 2026, with nearly 70 companies securing more than $9.1 billion, according to BioPharma Dive data. The bulk of the money cam…
    BioPharma Dive · 1mo agoDealNeutral↗ source
  • FDA proposes new rule to streamline registration of drug manufacturers' factories
    The FDA announced a proposed rule aimed at changing how factories that produce drugs for the U.S. market are registered with the agency. The change is intended to simplify the registration process…
    Endpoints · 1mo agoRegulatoryNeutral↗ source
  • HHS advances guidance to help patients discontinue antidepressants
    In a private meeting in Washington, officials from the Department of Health and Human Services met with mental-health clinicians to discuss a new clinical guidance aimed at deprescribing selective…
    STAT · 1mo agoRegulatoryNeutral↗ source
  • U.S. Health Secretary Robert F. Kennedy Jr. Advocates Deprescribing of Psychiatric Medications
    U.S. Health and Human Services Secretary Robert F. Kennedy Jr. is intensifying his campaign to encourage Americans to stop using psychiatric drugs, a strategy known as deprescribing. The effort, r…
    STAT · 1mo agoNeutral↗ source
  • Cayman court orders Apple Tree Partners to lose control of its venture fund
    A Cayman Islands court ruled that Apple Tree Partners' general partner must give up control of its venture fund. The decision follows a dispute with the fund's main limited partner, and the judge…
    Endpoints · 1mo agoNeutral↗ source
  • Airlines rely on volunteer doctors to handle common in‑flight medical complaints
    Physicians frequently volunteer to assist on commercial flights after a cabin announcement asks, “Is there a doctor on board?” The author, a hematologist‑oncologist, notes that he responded on thre…
    STAT · 1mo agoNeutral↗ source
  • Last U.S. polio patient who used an iron lung dies at 78
    Martha Lillard, diagnosed with polio at age five, became the last American still dependent on an iron lung. She lived in Oklahoma, attended grade school two hours a day and completed high school u…
    STAT · 1mo agoNeutral↗ source
  • Researchers Highlight Tau and Blood‑Brain Barrier Advances at Alzheimer’s Conference
    STAT’s AAIC in 30 newsletter reported that tau protein remains the central focus of Alzheimer’s research presented at the recent conference in London. Scientists discussed new strategies aimed at d…
    STAT · 1mo agoNeutral↗ source
  • Weekly roundup highlights Biohaven’s challenge to Eli Lilly and industry competition with China
    The latest Endpoints Weekly issue focuses on a series of recent deals across the biotech sector, offering readers a snapshot of market activity. Among the items highlighted is Biohaven’s strategic…
    Endpoints · 1mo agoDealNeutral↗ source
  • Roche stops two Huntington's disease gene-silencing programs after disappointing trial data
    Roche announced it is ending development of two gene‑silencing candidates aimed at Huntington's disease after data failed to meet expectations. The decision follows a recent readout that showed in…
    STAT · 1mo agoNegative↗ source
  • ARPA-H awards $160 M to accelerate bespoke gene‑editing therapies for rare diseases
    ARPA-H announced a $160 million, five‑year investment through its THRIVE program to speed the development of personalized gene‑editing treatments for rare genetic conditions. The awardees include…
    BioPharma Dive · 1mo agoNeutral↗ source
  • FDA rejects Hengrui-Elevar liver cancer drug combo for third time over manufacturing issues
    FDA has again turned down a liver cancer drug combination from Jiangsu Hengrui Pharmaceuticals and Elevar Therapeutics. This is the third rejection in roughly two years, with the agency citing per…
    Endpoints · 1mo agoRegulatoryNegative↗ source
  • US biotech firms grow more secretive amid rising competition from Chinese industry
    US biotech companies are becoming more secretive as competition from China’s rapidly expanding biotech sector intensifies. Janine Sengstack, a senior scientist at Junevity, says her team may have…
    Endpoints · 1mo agoNegative↗ source
  • German parliament approves cost-cutting health bill, pharma industry warns of exit risk
    German federal parliament voted to pass a bill aimed at reducing domestic healthcare expenditures. The legislation seeks to curb spending on medicines and other health services as part of a broade…
    Endpoints · 1mo agoRegulatoryNegative↗ source
  • Hansoh reports Phase 3 success for GSK‑partnered ADC in SCLC as FDA clears Sanofi on‑body injector
    Hansoh announced that its Phase 3 trial of the antibody‑drug conjugate Ris‑Rez met the primary endpoint in patients with small cell lung cancer. The study was conducted in partnership with GSK and…
    Endpoints · 1mo agoRegulatoryPositive↗ source
  • German Parliament votes to double mandatory drug rebate to 15.5%, sparking industry concerns
    German lawmakers have approved a bill that would raise the mandatory rebate that drug manufacturers must give the government on branded medicines from the current 7% to 15.5%. The increase is inte…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Apnimed announces IPO plans while FDA reviews its sleep-apnea therapy
    Apnimed, a Cambridge, Massachusetts biotech, disclosed that it will pursue an initial public offering on Nasdaq. The move comes as the company’s lead sleep‑apnea candidate is under review by the U…
    Endpoints · 1mo agoDealPositive↗ source
  • Nominee for HHS emergency response role has a history of questioning vaccines
    Sean Kaufman has been selected by the administration to lead the Office of Assistant Secretary for Preparedness and Response, overseeing the nation’s reaction to public health emergencies and disas…
    STAT · 1mo agoRegulatoryNegative↗ source
  • FDA resumes publishing pharma rejection letters, posting 14 new CRLs
    The FDA announced on Friday that it has posted fourteen new complete response letters (CRLs) to pharmaceutical companies on its website. This marks a return to the agency’s regular practice of mak…
    Endpoints · 1mo agoCRLNeutral↗ source
  • GSK, Hansoh ADC extends survival in lung cancer study
    GSK claimed the result was a first for an ADC aimed at the “B7-H3” protein, an increasingly popular target of late among cancer drugmakers.
    BioPharma Dive · 1mo agoRegulatoryNeutral↗ source